CIK 0001497253
- Non-accelerated filer
- Smaller reporting company
VivoSim Labs, INC.
Sign in to watch- Ticker
- VIVS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 271488943
- Phone
- +1 858-224-1000
- Business address
- 11555 SORRENTO VALLEY ROAD, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- ORGANOVO HOLDINGS, INC., REAL ESTATE RESTORATION & RENTAL, INC.
- Open-market buys, last 90 days
- $2,804
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$2,804. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-08-20 | HOWSON TAMAR D Director | Grant or award · Stock Option (Right to Buy) | +31,500 | 31,500 | ||
| 2014-08-20 | GLOVER JAMES T Director | Grant or award · Stock Option (Right to Buy) | +31,500 | 31,500 | ||
| 2014-08-20 | Heyman Richard A. Director | Grant or award · Stock Option (Right to Buy) | +31,500 | 31,500 | ||
| 2014-08-20 | Baltera Robert Jr. Director | Grant or award · Stock Option (Right to Buy) | +31,500 | 31,500 | ||
| 2014-06-06 | Baltera Robert Jr. Director | Option exercise | +3,000 | $1.00 | $3K | 144,506 |
| 2014-06-06 | Baltera Robert Jr. Director | Option exercise · Warrant (Right to Buy) | −3,000 | 0 | ||
| 2014-05-08 | Renard Michael EVP of Commercial Operations | Exercise or conversion | +50,000 | $1.65 | $83K | 50,000 |
| 2014-05-08 | Renard Michael EVP of Commercial Operations | Exercise or conversion · Stock Option (Right to Buy) | −50,000 | 500,000 | ||
| 2014-02-21 | Renard Michael EVP of Commercial Operations | Exercise or conversion | +10,000 | $1.65 | $17K | 10,000 |
| 2014-02-21 | Renard Michael EVP of Commercial Operations | Sale | −10,000 | $10.65 | $107K | 0 |
| 2014-02-21 | Renard Michael EVP of Commercial Operations | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 550,000 | ||
| 2014-02-19 | MICHAELS BARRY D Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2014-02-19 | Presnell Sharon Collins EVP, Research & Dev & CTO | Grant or award · Stock Option (Right to Buy) | +155,000 | 155,000 | ||
| 2014-02-19 | David Eric Chief Strategy Officer | Grant or award · Stock Option (Right to Buy) | +140,000 | 140,000 | ||
| 2014-02-19 | Renard Michael EVP of Commercial Operations | Grant or award · Stock Option (Right to Buy) | +155,000 | 155,000 | ||
| 2014-02-19 | Murphy Keith Chairman, CEO and President | Grant or award | +50,000 | 6,024,643 | ||
| 2014-02-19 | Murphy Keith Chairman, CEO and President | Shares withheld for taxes | −27,307 | $9.86 | $269K | 5,997,336 |
| 2014-02-19 | Murphy Keith Chairman, CEO and President | Grant or award · Stock Option (Right to Buy) | +27,307 | 27,307 | ||
| 2014-02-19 | Murphy Keith Chairman, CEO and President | Grant or award · Stock Option (Right to Buy) | +550,000 | 550,000 | ||
| 2014-02-18 | Murphy Keith Chairman, CEO and President | Sale | −100,000 | $9.82 | $982K | 5,974,643 |
Page 14 of 18 · 356 trades